| Autor: |
Dreyling M; Department of Medicine III, University of Munich, Munich, Germany., Geisler C; Hematology Clinic, Rigshospitalet, Copenhagen, Denmark., Hermine O; Department of Hematology, Imagine Institute and Descartes University, INSERM U1163 and CNRS ERL 8564, Necker Hospital, Paris, France., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Le Gouill S; Service d'hématologie Clinique, CHU de Nantes, Université de Nantes, Nantes, France., Rule S; Peninsula School of Medicine and Dentistry, University of Plymouth, Plymouth, UK., Shpilberg O; Institute of Hematology, Assuta Medical Center, Tel-Aviv, Israel., Walewski J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute and Oncology Centre, Warsaw, Poland., Ladetto M; Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. |
